IND enabling studies for a group a strep vaccine
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00037
- Awardee
-
Vaxform LLC UEI L2PLXD4EA569
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Fountain Hill, PA 18015, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Vaxform LLC. The contract is for Phase I of the Small Business Innovation Research program and involves enabling studies for a Group A Strep vaccine. The work will be performed in Fountain Hill, Pennsylvania over a period of 13 months concluding in October 2022. This award was made under a total small business set aside solicitation from NIH and the Centers for Disease Control and Prevention seeking proposals aligned with agency missions through the SBIR program. Key research areas included infectious diseases and public health preparedness. The contract supports the agencies' goals of fostering innovation to address health challenges.
Quick answers
Who was awarded contract 75N93021C00037?
75N93021C00037 was awarded to Vaxform LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2021.
How much is contract 75N93021C00037 worth?
The government has obligated $300,000 on 75N93021C00037.
Was contract 75N93021C00037 competed?
The extent of competition for 75N93021C00037 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award